Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis

por Navarro-López, Vicente, Méndez-Miralles, María Ángeles, Vela-Yebra, Rosa, Fríes-Ramos, Ana, Sánchez-Pellicer, Pedro, Ruzafa-Costas, Beatriz, Núñez-Delegido, Eva, Gómez-Gómez, Humberto, Chumillas-Lidón, Sara, Picó-Monllor, Jose A., Navarro-Moratalla, Laura
Publicado 2022

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

por Fernandez‐Diaz, Eva, Perez‐Vicente, Jose A., Villaverde‐Gonzalez, Ramon, Berenguer‐Ruiz, Leticia, Candeliere Merlicco, Antonio, Martinez‐Navarro, Maria Luisa, Gracia Gil, Julia, Romero‐Sanchez, Carlos M., Alfaro‐Saez, Arantxa, Diaz, Inmaculada, Gimenez‐Martinez, Juana, Mendez‐Miralles, Maria Angeles, Millan‐Pascual, Jorge, Jimenez‐Pancho, Javier, Mola, Santiago, Sempere, Angel P.
Publicado 2020